T-cell costimulation modulator
This page covers all T-cell costimulation modulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD80/CD86.
Targets
Phase 3 pipeline (2)
- Subcutaneous (SC) abatacept · Bristol-Myers Squibb · Immunology
Abatacept is a fusion protein that blocks T-cell costimulation by binding to CD80/CD86 on antigen-presenting cells, thereby inhibiting T-cell activation and proliferation. - Abatacept plus · Massachusetts General Hospital · Immunology
Abatacept is a fusion protein that blocks T-cell costimulation by binding to CD80/CD86 on antigen-presenting cells, thereby inhibiting T-cell activation and proliferation.